WELL Health Technologies Corp

03/06/2026

WELL is pleased to announce that the Company will release its Fiscal Fourth Quarter and Year End 2025 financial results for the period ended December 31, 2025, before market open on Thursday, March 19, 2026.

The Company will hold a conference call and simultaneous webcast to discuss its results on the same day, at 1:00 pm ET (10:00 am PT). The call will be hosted by Hamed Shahbazi, Chairman and Chief Executive Officer, and Eva Fong, Chief Financial Officer.

Visit well.company/events to register for the webcast.

02/24/2026

WELL a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to provide a corporate update on its Canadian Patient Services business, highlighting record patient visits, strong patient satisfaction scores, increasing clinic footprint, and a growing practitioner base across its national network in 2025.

🔗 To learn more, please follow the link below.
https://ow.ly/VhA350Yl1yH

02/19/2026

WELL, a technology-enabled healthcare company operating outpatient clinics that leverage scalable digital health solutions, and HEALWELL AI Inc. (“HEALWELL”) (TSX: AIDX) (OTCQX: HWAIF), a healthcare artificial intelligence company focused on preventative care, are jointly pleased to announce the launch of the first phase of WELLTRUST™, a platform enabling secure, consent-driven patient identification for clinical research within WELL-operated clinics in Canada.

🔗 To learn more, please follow the link below.
https://ow.ly/JGl150Yi7wk

02/04/2026

WELL a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to provide a corporate update highlighting the expansion and extension of its senior secured credit facility and the completion of the strategic acquisition of a leading e-consult platform in Alberta, Canada, consisting of a technology enabled e-consult healthcare services business and a network of eight primary care clinics largely based in the Calgary region.

To learn more, please follow the link below. 🔗
https://ow.ly/OLig50Y8OsA

01/21/2026

WELL is pleased to announce the release of a letter to shareholders from its Founder, Chairman and Chief Executive Officer, Hamed Shahbazi, outlining the Company’s strategic priorities for 2026 and the principles guiding its next phase of growth.

The CEO letter can be accessed below.

https://ow.ly/XLvi50Y0Pwj

01/09/2026

Big congratulations to Hamed Shahbazi, CEO of WELL Health Technologies, on being named Cantech’s TSX Tech Executive of the Year 🎉

In this interview, Hamed shares how WELL is transforming outpatient care across Canada and what’s next for 2026, including the subsidiary.

▶️ Watch now: https://www.youtube.com/watch?v=8FjMnITstj8

An interview with Hamed Shahbazi, the CEO of WELL Health Technologies, who recently won Cantech's TSX Tech Executive of the Year.

12/19/2025

🎁 WELL Gives Back! ❤️

Sharing a few photos from our recent volunteering initiative! A group of team members from WELL HQ and our BC clinic teams spent time with CityReach Care Society , wrapping gifts and preparing festive packages for their annual Boxes of Love event — an initiative that brings Christmas joy and support to vulnerable families across the Greater Vancouver area.

These gifts will be given to over 2,000 children and families, helping make the season a little brighter through thoughtful presents, treats, and essentials. We’re proud to support our community and contribute alongside CityReach in spreading hope and holiday cheer. 🎄✨

Thank you to everyone who volunteered! Your time and heart truly make a difference! 💛

12/08/2025

WELL a digital healthcare company focused on improving health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its majority-owned subsidiary WELLSTAR Technologies Corp. (“WELLSTAR”) has completed its previously announced Series B Preferred Share financing (the “Series B Financing”), raising aggregate gross proceeds of approximately $62 million.

📌 WELLSTAR announces it has closed on a $62 million equity placement supported by Mawer Investment Management, Edgepoint Wealth Management, PICTON Investments and the management team of WELL and WELLSTAR to fund its pre-spinout growth objectives.

📌 WELLSTAR is a high growth, profitable, pure-play SaaS healthcare technology company serving over 40% of providers across Canada with high quality technology and services that significantly improve patient care.

https://ow.ly/hnLW50XFLgC

12/08/2025

WELL a digital healthcare company focused on improving health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its majority-owned subsidiary WELLSTAR Technologies Corp. (“WELLSTAR”) has completed its previously announced Series B Preferred Share financing (the “Series B Financing”), raising aggregate gross proceeds of approximately $62 million.

📌 WELLSTAR announces it has closed on a $62 million equity placement supported by Mawer Investment Management, Edgepoint Wealth Management, PICTON Investments and the management team of WELL and WELLSTAR to fund its pre-spinout growth objectives.

📌 WELLSTAR is a high growth, profitable, pure-play SaaS healthcare technology company serving over 40% of providers across Canada with high quality technology and services that significantly improve patient care.

To learn more, please follow the link below. 🔗
https://ow.ly/Ye8850XFLnV

11/24/2025

This November, we were honoured to participate in the Infoway Partnership Conference 2025 alongside Wellstar, OceanMD, and HealWell AI. Amir Javidan, Chief Executive Officer of WELLSTAR, delivered the opening remarks ahead of the day one closing keynote and joined a panel discussion - valuable opportunities to engage with the public sector community on connected care, interoperability, and positively impacting healthcare outcomes across Canada.

Thank you to the Infoway for the thoughtful dialogue and the value this gathering brings yearly! 🚀

11/20/2025

WELL is pleased to announce continued momentum across its Canadian Patient Services business driven by strong organic growth, meaningful improvements in clinic digitization, and successful ex*****on on its primary care patient opening initiative. Please see key highlights below.

📌 WELL is pleased to provide enhanced disclosure on its organic growth metrics, including detailed breakdowns of same-clinic growth and absorption-driven organic growth.

📌 Overall same clinic revenue growth across WELL Medical Centres (“WMC”) and WELL Diagnostics Centres (“WDC”) was 10% and 16% YoY respectively.

📌 WELL disclosed that it has achieved 92% digitization for all primary care clinics that have been in its network for longer than 9 months.

📌 On June 24, 2025, WELL announced that it had created availability for over 45,000 new primary care patient openings across 3 provinces enabled by investments in physician recruitment and digital transformation. WELL is pleased to report that as of October 31, 2025, it had already filled 25,000 of these new openings and expects to fully satisfy the balance by end of Q1.

To learn more, please follow the link below. 🔗

https://ow.ly/CKx750XuRZz

11/13/2025

WELL is pleased to provide a corporate update on its majority-owned platform subsidiary, Wellstar, including recent developments related to OceanMD's eReferral platform, recent strategic acquisitions, and the completion of a $62 million Series B financing round. Please see key highlights below.

📌 WELLSTAR's OceanMD has been awarded a material eReferral contract with a Canadian province following a competitive procurement process.

📌 WELLSTAR’s OceanMD is Canada’s eReferral market leader with programs in four Canadian provinces now facilitating over 1.7 million eReferrals annually nationwide with participation from more than 20,000 physicians and 3,800 clinics.

📌 WELLSTAR has signed three M&A-related transactions in November, including leading-edge Ambient AI Scribe Mutuo and two others within the Company’s billing unit.

📌 WELLSTAR recently released its Q3 financials, which demonstrated accelerated organic growth of 26% with overall YoY revenue growth of 67%.

📌 On October 31, 2025, WELLSTAR announced that it had executed an agreement with a leading group of institutional investors to raise $62 million to execute on growth opportunities. WELLSTAR has added a new member to its corporate development team and is aggressively pursuing its M&A pipeline.

To learn more, please follow the link below. 🔗

https://ow.ly/YHhw50Xrh89